MN-001 is an anti-inflammatory agent.1 In vivo, MN-001 (10, 30, and 50 mg/kg) reduces the frequency of bladder voids, increases the intercontractile interval, and decreases the number of non-voiding contractions in a rat model of bladder hyperactivity induced by ovalbumin-induced mast cell stimulation.
1.Rajasekaran, M., Locke, K.W., and Parsons, C.L.MN-001, a novel oral anti-inflammatory agent, suppresses bladder hyperactivity in a rat modelBJU Int.98(2)430-434(2006)
















